| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Urogen Pharma Ltd. (URGN) has 10 insiders with recent SEC Form 4 filings, including 1 buy and 6 sells. URGN is classified in the Biotechnology industry within the Health Care sector.
| Role | Insider | Shares | Value | 30d |
|---|---|---|---|---|
| CEO | 153.2K | $5.36M | - | |
| Other | 55.6K | $1.95M | - | |
| Dir | 20.0K | $699.8K | - | |
| CFO | 2.3K | $79.8K | - | |
| Dir | 2.0K | $70.0K | - |
Buys and sells only
| Date | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|
| Aug 15, 2019 | Mullennix Stephen | Chief Operating Officer | Sale+OE | 608 | $31.65 | $19,243.20 | -8.5% | |
| May 14, 2019 | Mullennix Stephen | Chief Operating Officer | Sale+OE | 608 | $37.98 | $23,091.84 | -10.2% | |
| Mar 21, 2019 | Schoenberg Mark60 | Chief Medical Officer | Buy | 272 | $37.01 | $10,066.45 | +6.3% | |
| Mar 6, 2019 | Schoenberg Mark60 | Chief Medical Officer | Sale+OE | 1,991 | $37.30 | $74,264.30 | -31.5% | |
| Feb 14, 2019 | Mullennix Stephen | Chief Operating Officer | Sale+OE | 2,804 | $37.30 | $104,589.20 | -39.9% | |
| Nov 28, 2017 | Proquest Investments Iv, L.P. | 10% Owner | Sell | 209,298 | $40.60 | $8,497,871.49 | -7.3% |